DDrare: Database of Drug Development for Rare Diseases

Searched query = "Ehlers-Danlos syndrome", "EDS", "cEDS", "hEDS", "clEDS", "vEDS", "kEDS", "aEDS", "dEDS", "DDEDS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 0.9% Sodium Chloride Injection; Bupivacaine; Bupivacaine Injection 0.5%; Celiprolol; Chloride; Control; Device: Kera-X; IRBESARTAN; Irbesartan; Lidocaine; Lidocaine Injection 2%; Mecasermin; Mind-body therapy; Riboflavin; Saline; Sodium chloride

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01446783 (ClinicalTrials.gov)	September 2011	27/9/2011	IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients	IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients	Ehlers-Danlos Syndrome, Classic	Drug: mecasermin;Drug: Saline	Bispebjerg Hospital	NULL	Completed	18 Years	N/A	Both	15	N/A	Denmark

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01446783
(ClinicalTrials.gov)

September 2011

27/9/2011

IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients

Ehlers-Danlos Syndrome, Classic

Drug: mecasermin;Drug: Saline

Bispebjerg Hospital

NULL

Completed

18 Years

N/A

Both

N/A

Denmark